HYPD Hyperion DeFi shares gain 1667 percent despite Q4 2025 earnings falling far short of analyst estimates Indaptus Therapeutics INDP Stock Is It a Good Entry Point Indaptus Therapeutics misses EPS views no revenue How fund distributions IonQ IONQ Selling Pressure 20260427 ANF A and F delivers 2 percent Q1 2026 EPS beat shares fall 239 percent on muted investor sentiment Apple Inc AAPL Bullish Endorsements Highlight Underappreciated Catalysts Amid Flat YeartoDate Performance